Open Access
| Issue |
BIO Web Conf.
Volume 55, 2022
5th International Conference on Frontiers of Biological Sciences and Engineering (FBSE 2022)
|
|
|---|---|---|
| Article Number | 01010 | |
| Number of page(s) | 4 | |
| DOI | https://doi.org/10.1051/bioconf/20225501010 | |
| Published online | 21 November 2022 | |
- HANAHAN D, WEINBERG R A. Hallmarks of cancer: the next generation[J]. Cell, 2011, 144(5): 646-674. DOI: 10.1016/j.cell.2011.02.013. [CrossRef] [PubMed] [Google Scholar]
- BHATIA A, KUMAR Y. Cellular and molecular mechanisms in cancer immune escape: a comprehensive review[J]. Expert Rev Clin Immunol, 2014, 10(1): 41-62. DOI:10.1586/1744666X.2014.865519. [CrossRef] [PubMed] [Google Scholar]
- GAO M, GAO L, YANG G, et al. Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism[J]. Acta Biochim Biophys Sin (Shanghai), 2014, 46(7): 597-604. DOI:10.1093/abbs/gmu041. [CrossRef] [PubMed] [Google Scholar]
- JAKOBSSON T, TREUTER E, GUSTAFSSON J A, et al. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities[J]. Trends Pharmacol Sci, 2012, 33(7): 394-404. DOI:10.1016/j.tips.2012.03.013. [CrossRef] [PubMed] [Google Scholar]
- Egen J G, Kuhns M S, Allison J P. CTLA-4:new insights into its biological function and use in tumor immunotherapy[J]. Nature Immunology, 2002, 3(7):611. [CrossRef] [PubMed] [Google Scholar]
- Cao A Z, Daniel D, Hanahan D. Sub-lethal radiation enhances anti-tumor immunotherapy in a transgenic mouse model of pancreatic cancer[J]. BMC Cancer, 2002, 2. [Google Scholar]
- Ochoa J. Increased circulating nitrogen oxides after human tumor immunotherapy with toxic hemodynamic changes[J]. J Natl Cancer Inst, 1992, 84. [Google Scholar]
- Min C, Jian Z, Wen J, et al. Natural killer cell lines in tumor immunotherapy[J]. Frontiers of Medicine, 2012, 6(001):56-66. [CrossRef] [PubMed] [Google Scholar]
- Nelson D, Fisher S, Robinson B. The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment[J]. Journal of Immunology Research, 2014, (2014-5-18), 2014, 2014:789069. [Google Scholar]
- Jakobisiak M, Golab J, Lasek W. Interleukin 15 as a promising candidate for tumor immunotherapy[J]. Cytokine & Growth Factor Reviews, 2011, 22(2):99-108. [CrossRef] [PubMed] [Google Scholar]
- Korman A, Yellin M, Keler T. Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies[J]. Curr Opin Investig Drugs, 2005, 6(6):582-591. [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.